{
    "root": "9f55185f-8471-4477-97b2-b61dd50c8b44",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Quetiapine Fumarate",
    "value": "20250227",
    "ingredients": [
        {
            "name": "QUETIAPINE FUMARATE",
            "code": "2S3PL1B6UJ"
        },
        {
            "name": "DIBASIC CALCIUM PHOSPHATE DIHYDRATE",
            "code": "O7TSZ97GEP"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "HYPROMELLOSE 2910 (6 MPA.S)",
            "code": "0WZ8WG20P6"
        },
        {
            "name": "POLYETHYLENE GLYCOL 400",
            "code": "B697894SGQ"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        }
    ],
    "indications": "quetiapine tablets , usp atypical antipsychotic indicated treatment schizophrenia ( 1.1 ) bipolar disorder manic episodes ( 1.2 ) bipolar disorder , depressive episodes ( 1.2 )",
    "contraindications": "quetiapine tablets taken without food ( 2.1 ) indication initial dose recommended dose maximum dose schizophrenia - adults ( 2.2 ) 25 mg twice daily 150-750 mg/day 750 mg/day schizophrenia - adolescents ( 13-17 years ) ( 2.2 ) 25 mg twice daily 400-800 mg/day 800 mg/day bipolar mania - adults monotherapy adjunct lithium divalproex ( 2.2 ) 50 mg twice daily 400-800 mg/day 800 mg/day bipolar mania - children adolescents ( 10-17 years ) , monotherapy ( 2.2 ) 25 mg twice daily 400-600 mg/day 600 mg/day bipolar depression - adults ( 2.2 ) 50 mg daily bedtime 300 mg/day 300 mg/day geriatric : consider lower starting dose ( 50 mg/day ) , slower titration careful monitoring initial dosing period elderly ( 2.3 , 8.5 ) hepatic impairment : lower starting dose ( 25 mg/day ) slower titration may needed ( 2.4 , 8.7 , 12.3 )",
    "warningsAndPrecautions": "quetiapine tablets , usp supplied 25 mg tablets : peach colored , circular , biconvex , film coated tablets , `` u `` debossed one side `` 25 `` side . blistercards 30 : ndc 0615-8470-39 blistercards 28 : ndc 0615-8470-28 blistercards 15 : ndc 0615-8470-05 unit dose boxes 30 : ndc 0615-8470-30 50 mg tablets : white colored , circular , biconvex , film coated tablets , `` u `` debossed one side `` 50 `` side . blistercards 30 : ndc 0615-8471-39 blistercards 28 : ndc 0615-8471-28 blistercards 15 : ndc 0615-8471-05 unit dose boxes 30 : ndc 0615-8471-30 100 mg tablets : yellow colored , circular , biconvex , film coated tablets , `` u `` debossed one side `` 100 `` side . blistercards 30 : ndc 0615-8472-39 blistercards 15 : ndc 0615-8472-05 200 mg tablets : white off-white colored , circular , biconvex , film coated tablets , `` u `` debossed one side `` 200 `` side . blistercards 30 : ndc 0615-8473-39 300 mg tablets : white off-white colored , oblong , film coated tablets , `` u `` debossed one side `` 300 `` side . blistercards 30 : ndc 0615-8474-39 400 mg tablets : yellow colored , oblong , film coated tablets , `` u `` debossed one side `` 400 `` side . blistercards 30 : ndc 0615-8568-39 store 20o 25oc ( 68o 77o f ) . [ usp controlled room temperature . ]",
    "adverseReactions": "known hypersensitivity quetiapine components formulation . ( 4 )",
    "indications_original": "Quetiapine tablets, USP are an atypical antipsychotic indicated for the treatment of Schizophrenia ( 1.1 ) Bipolar I disorder manic episodes ( 1.2 ) Bipolar disorder, depressive episodes ( 1.2 )",
    "contraindications_original": "Quetiapine tablets can be taken with or      without food ( 2.1 ) Indication Initial Dose Recommended Dose Maximum Dose Schizophrenia  - Adults  (2.2) 25 mg twice daily 150-750 mg/day 750 mg/day Schizophrenia  - Adolescents (13-17 years) (2.2) 25 mg twice daily 400-800 mg/day 800 mg/day Bipolar Mania  - Adults Monotherapy or as an adjunct  to lithium or divalproex (2.2) 50 mg twice daily 400-800 mg/day 800 mg/day Bipolar Mania  - Children and Adolescents (10-17 years), Monotherapy (2.2) 25 mg twice daily 400-600 mg/day 600 mg/day Bipolar Depression  - Adults (2.2) 50 mg once daily at bedtime 300 mg/day 300 mg/day Geriatric Use : Consider a lower starting dose (50 mg/day), slower titration      and careful monitoring during the initial dosing period in the elderly ( 2.3 , 8.5 ) Hepatic Impairment: Lower starting dose (25 mg/day) and slower titration may be      needed ( 2.4 , 8.7 , 12.3 )",
    "warningsAndPrecautions_original": "Quetiapine Tablets, USP are supplied as\n                  \n                  \n                     25 mg Tablets: Peach colored, circular, biconvex, film coated tablets, with \"U\" debossed on one side and \"25\" on the other side.\n                  Blistercards of 30:  NDC 0615-8470-39\n                  Blistercards of 28:  NDC 0615-8470-28\n                  Blistercards of 15:  NDC 0615-8470-05\n                  Unit Dose boxes of 30: NDC 0615-8470-30\n                  \n                     50 mg Tablets: White colored, circular, biconvex, film coated tablets, with \"U\" debossed on one side and \"50\" on the other side.\n                  Blistercards of 30:  NDC 0615-8471-39\n                  Blistercards of 28:  NDC 0615-8471-28\n                  Blistercards of 15:  NDC 0615-8471-05\n                  Unit Dose boxes of 30: NDC 0615-8471-30\n                  \n                     100 mg Tablets: Yellow colored, circular, biconvex, film coated tablets, with \"U\" debossed on one side and \"100\" on the other side.\n                  Blistercards of 30:  NDC 0615-8472-39\n                  Blistercards of 15:  NDC 0615-8472-05\n                  \n                     200 mg Tablets: White to off-white colored, circular, biconvex, film coated tablets, with \"U\" debossed on one side and \"200\" on the other side.\n                  Blistercards of 30:  NDC 0615-8473-39\n                  \n                     300 mg Tablets: White to off-white colored, oblong, film coated tablets, with \"U\" debossed on one side and \"300\" on the other side.\n                  Blistercards of 30:  NDC 0615-8474-39\n                  \n                     400 mg Tablets: Yellow colored, oblong, film coated tablets, with \"U\" debossed on one side and \"400\" on the other side.\n                  Blistercards of 30:  NDC 0615-8568-39\n                  Store at 20o to 25oC (68o to 77o F). [see USP Controlled Room Temperature.]",
    "adverseReactions_original": "Known hypersensitivity to quetiapine or any components in the formulation. ( 4 )"
}